Arthur Day

Title: Arthur Day: Innovator in Brain Receptor Treatments

Introduction

Arthur Day is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of neuroscience through his innovative work on brain receptor treatments. His research focuses on developing compositions that target specific nicotinic receptor subtypes, which are crucial for various neurological functions.

Latest Patents

Arthur Day holds a patent for "Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines." This invention relates to compositions designed for treating conditions associated with defects or malfunctioning of nicotinic subtypes of brain receptors. The compositions specifically target the alpha7 receptor subtype while minimizing activation of the alpha4beta2 or other receptor subtypes. This targeted approach has the potential to improve treatment outcomes for various neurological disorders.

Career Highlights

Arthur Day is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to collaborate with other researchers and contribute to advancements in the understanding of brain receptor functions. His innovative approach has garnered attention in the scientific community, highlighting the importance of targeted therapies in neuroscience.

Collaborations

Some of Arthur Day's notable coworkers include Edwin M Meyer and William Reade Kem. Their collaborative efforts have furthered research in the field and contributed to the development of effective treatments for neurological conditions.

Conclusion

Arthur Day's contributions to the field of neuroscience through his innovative patent demonstrate the potential for targeted therapies in treating brain receptor-related conditions. His work continues to inspire advancements in medical research and treatment methodologies.